Level D· Scientific groundwork from lab and animal studiesAnimal StudyEurope PMCOpen access

N6-Methyladenosine-Modified circSMAD4 Prevents Lumbar Instability Induced Cartilage Endplate Ossification

Li H., Tang Y., Hu S., Ruan X., Zhang J., Shi Y.

Animal Study on Disc Degeneration, published in Adv Sci (Weinh) (2025) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Animal Study
Journal
Adv Sci (Weinh) (2025)
Reported sample size
—
Source database
Europe PMC
PMID
39936497
PMCID
PMC11967797
DOI
10.1002/advs.202413970
Citations
5

Abstract (original English)

Lumbar instability causes cartilage endplate ossification and intervertebral disc degeneration. In this study, it is determined that circSMAD4, a Yap1-related circRNA, is stably downregulated under abnormal stress. In vitro, circSMAD4 knockdown resulted in Yap1 mRNA degradation, whereas circSMAD4 overexpression increased Yap1 mRNA expression and nuclear translocation. Hence, the stabilization of circSMAD4 is essential for maintaining the homeostasis of endplate cartilage under abnormal stress. Furthermore, transcriptome sequencing and mass spectrometry analysis revealed that METTL14-mediated N 6 -methyladenosine (m 6 A) modification can stabilize circSMAD4 expression. Moreover, circSMAD4 is shown to regulate Yap1 mRNA through the m6A reader IGF2BP1. The IGF2BP1 functions to translocate Yap1 mRNA into the nucleus, which protects endplate chondrocytes from degeneration. Finally, local injection of an AAV5-containing circSMAD4 overexpression plasmid successfully rescued LSI-induced cartilage endplate degeneration, which wasn't observed in Yap1 knockout mice. These findings suggest that m6A-modified circSMAD4 can stabilize Yap1 mRNA expression and translocation, thus preventing degeneration of the cartilage endplate under abnormal stress. Hence, circSMAD4 may become a potential therapeutic tool for managing instability-induced intervertebral disc degeneration.

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
CartilageLumbar VertebraeChondrocytesAnimalsMice, Inbred C57BLMice, KnockoutHumansMiceAdenosineOsteogenesis

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research